Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
This study is to determine the efficacy (how well the drug works), safety, and side effects
of the study medication compared to placebo in the treatment of the negative symptoms of
schizophrenia in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.